13 results
Validation of the Step-By-Step Approach to Febrile Infants

#Diagnosis #Management #Pediatrics #Peds #Febrile #Infant #StepByStep #Algorithm #LP
Management #Pediatrics #Peds ... Infant #StepByStep #Algorithm ... Antibiotics #Risk #Stratification
Pediatric UTI Algorithm (2-24 months of age)

Risk stratify with UTI Calc: 
 - Age months
Pediatric UTI Algorithm ... Pediatric #UTI #Algorithm ... UrinaryTractInfection #Peds ... #Risk #Stratification
Validation of the “Step-by-Step” Approach in the Management of Young Febrile Infants
Visual Abstract by Dr. Kirsty
27382134 #EBM #Peds ... VisualAbstract #StepByStep #Algorithm ... #Infant #Risk #Stratification
Combination of diagnostic criteria used to assess the severity of tricuspid regurgitation (TR). This figure lists
described by Grant et ... al.60 In this algorithm ... color Doppler jet
Causes of Non-Gap Metabolic Acidosis - Differential Diagnosis Algorithm
Normal Anion Gap (<14) (Loss of Bicarbonate) -
Differential Diagnosis Algorithm ... Negative urine net ... Loss Negative U net ... Differential #Diagnosis #Algorithm
“Step by Step” – the new kid on the block – aims to risk stratify this
components of the algorithm ... Management #Pediatrics #Peds ... Infant #StepByStep #Algorithm ... Antibiotics #Risk #Stratification
Threshold for Initiating Exchange Transfusion by Risk Stratum. Bhutani et al. Pediatrics. 1999.

#Peds #Pediatrics #Diagnosis #Management
Bhutani et al. ... #Peds #Pediatrics ... Hyperbilirubinemia #Risk #Stratification
Risk Stratification for Developing Severe Hyperbilirubinemia. Bhutani et al. Pediatrics. 1999.

In general, babies at low-risk and
Risk Stratification ... Bhutani et al. ... #Peds #Pediatrics ... Hyperbilirubinemia #Risk #Stratification
Evaluation of suspected incomplete Kawasaki Disease

1. AHA consensus recommendations
2. Infants ≤6 months old on day ≥7
purposes of this algorithm ... 3 conditions met ... #Diagnosis #Peds ... Disease #Incomplete #Algorithm
Esophageal Variceal Bleeding - Scoping Summary
GENERAL PRINCIPLES OF MANAGEMENT (VARICEAL-B):
V - Vasoconstrictor therapy: (Octreotide 50mcg bolus
acquired/vasoactive meds ... outcomes Hayat et ... diagnosis #management #algorithm